Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Xa Activity”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT00986635
What this trial is testing

Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

Who this might be right for
Differences in Laboratory Coagulation Parameters
Johann Wolfgang Goethe University Hospital 100
Post-approval studies (Phase 4)Study completedNCT03363035
What this trial is testing

Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionMyocardial Ischemia+1 more
Second Xiangya Hospital of Central South University 2,055
Not applicableNot Yet RecruitingNCT07365670
What this trial is testing

Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)

Who this might be right for
Congenital Heart DiseaseUnfractionated HeparinAnti Xa Activity
Centre Hospitalier Universitaire de la Réunion 22
Not applicableLooking for participantsNCT06357403
What this trial is testing

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

Who this might be right for
ThrombosisPulmonary EmbolismEnoxaparin
Medical University of Vienna 1,300
Post-approval studies (Phase 4)Study completedNCT00555438
What this trial is testing

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

Who this might be right for
Major Orthopaedic Surgery and Renal Impairment
Centre Hospitalier Universitaire de Saint Etienne 451
Large-scale testing (Phase 3)UnknownNCT04999176
What this trial is testing

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Who this might be right for
CancerRivaroxabanVenous Thromboembolism+1 more
André Luiz Malavasi Longo de Oliveira 440
Not applicableWithdrawnNCT05554055
What this trial is testing

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)

Who this might be right for
Aortic DiseasesArterial DiseaseThrombosis
Hospices Civils de Lyon
Post-approval studies (Phase 4)UnknownNCT02957877
What this trial is testing

LMWH Infusion as Anticoagulation for Home HD

Who this might be right for
Endstage Renal Disease
Alice Ho Miu Ling Nethersole Hospital 12
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726
What this trial is testing

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Les Laboratoires des Médicaments Stériles 120
Post-approval studies (Phase 4)UnknownNCT03426982
What this trial is testing

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

Who this might be right for
Myocardial InfarctionVenous ThromboembolismStroke+1 more
Wuhan Asia Heart Hospital 700
Not applicableLooking for participantsNCT07183605
What this trial is testing

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Who this might be right for
Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans 30
Not applicableUnknownNCT05993533
What this trial is testing

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Who this might be right for
Venous Thromboembolic Disease
Direction Centrale du Service de Santé des Armées 100
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Not applicableLooking for participantsNCT06431789
What this trial is testing

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Who this might be right for
Gene PolymorphismEdoxabanRenal Insufficiency
Yi Han 220
Not applicableNot Yet RecruitingNCT07213713
What this trial is testing

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Who this might be right for
Venous ThromboembolismObese Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Not applicableStudy completedNCT02925247
What this trial is testing

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Assistance Publique Hopitaux De Marseille 150
Post-approval studies (Phase 4)UnknownNCT02295150
What this trial is testing

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Who this might be right for
Morbid ObesityThromboembolismBypass Complications
Rijnstate Hospital 50
Post-approval studies (Phase 4)Looking for participantsNCT05672550
What this trial is testing

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)

Who this might be right for
Pediatric Kidney Transplant Recipients
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Ended earlyNCT00437697
What this trial is testing

Thromboprophylaxis in Critically Ill Patients

Who this might be right for
Venous Thromboembolism
Medical University of Vienna 90
Early research (Phase 1)Study completedNCT00618579
What this trial is testing

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

Who this might be right for
Healthy
ThromboGenics 15
Load More Results